Pharmaceutical
| Sun 27 Sep 2026
Alexandria, Sept. 26 -- U.S. Patent and Trademark Office has published Metagenomi Therapeutics Inc patent application for Class 2, Type V Crispr Systems. The invention was developed by Brown Christopher, Brothers Molly, Alexander Lisa, Castanzo Dominic, Goltsman Daniela S A, Matheus Carnevali Paula B, Thomas Brian C, Castelle Ci..